|
- Encoded Therapeutics – Translating Next-Generation Science into . . .
Translating Next-Generation Science Into Transformative Gene Therapies Learn About Our Programs
- News – Encoded Therapeutics
News Events Press Releases March 25, 2026 Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome January 12, 2026 Encoded Therapeutics Announces U S FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome January
- Programs – Encoded Therapeutics
Encoded is building an internally developed pipeline of best- and potentially first-in-class therapies focused on pediatric central nervous system (CNS) disorders
- Clinical Studies – Encoded Therapeutics
Data from observational studies and clinical trials, which depend on volunteer participants, form the foundation of regulatory authorities’ decisions to approve new therapies for broader use
- About – Encoded Therapeutics
Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients Our diversity – whether gender, ethnicity, sexual orientation, religion, age or disability – is one of our biggest strengths as an organization
- Contact – Encoded Therapeutics
Contact Directory Patients Community and Clinical Trials patientadvocacy@encoded com Healthcare Providers medinfo@encoded com Media communications@encoded com Finance Accounting ap@encoded com Partnering partnering@encoded com Careers careers@encoded com General Information info@encoded com
- Encoded Therapeutics Announces U. S. FDA Breakthrough Therapy . . .
Encoded Therapeutics Announces U S FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome – Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – SOUTH SAN FRANCISCO, Calif — January 12, 2026 — Encoded Therapeutics, Inc (“Encoded”), a clinical-stage biotechnology company developing precision
- Our Science – Encoded Therapeutics
Our Science The precision gene therapies being developed at Encoded are designed to modulate gene expression within specific cell types to potentially address the underlying disease mechanism Neurological disorders can lead to premature mortality and lifelong disability in children and adults globally
|
|
|